COST given budget boost for FP7

COST, the European Cooperation in Science and Technology, will continue to be managed by the European Science Foundation (ESF) under the Seventh Framework Programme (FP7). The European Commission and ESF signed a contract to this effect at the end of July.

Under the Sixth Framework Programme (FP6), EU support for COST amounted to €80 million, a figure which is set to rise to €210 million under FP7. An additional €40 million could be added to the pot if a mid-term evaluation in 2010 is successful.

"The contract and the increase in funding is indeed a strong vote of confidence towards the ESF-COST cooperation," said Dr Martin Grabert, Director of the COST Office. "With this contract, we can truly capitalise on previous successes. We will not rest on our laurels, however, and continue to focus on cross-disciplinary initiatives and strengthening the synergy between the various research actors in Europe."

The bigger budget will allow COST to expand its activities and boost support for both the scientific and technical committees and the COST Actions (networks of researchers).

The contract sets out a series of work packages which reflect the increase in funding through new and expanded activities, the development of new ideas for interdisciplinary science initiatives and a greater exploitation of the European 'Near Neighbours' policy. There is also a stronger focus on outreach and communications.

"The negotiation of this contract and the transition between FP6 and FP7 were two challenging processes," commented David Weber, the ESF's Director of Administration and Finance, noting that the ESF's commitment to COST, coupled with its experience of managing such a complex operation, had been key to the successful completion of the agreement.

"I very much welcome the positive conclusion of the negotiations for the signature of the EC-ESF contract for COST," added Professor Francesco Fedi, President of the COST Committee of Senior Officials. "COST has always been a unique instrument with a strong role to play towards the development of the ERA. Typical COST features such as its flexibility and bottom-up approach make it a perfect platform for innovative ideas on the frontiers of science."

A recent independent review of the Commission-ESF COST contract for FP6 noted the high levels of satisfaction among users of COST and concluded that the switchover from the COST Action managed by the European to the COST Office run by the ESF had been largely successful.

Established in 1971, COST is now used by researchers in 35 European countries to cooperate in common research projects supported by national funds.

For more information, please visit:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...